Clinical Trials Browser

Phase EARLY_PHASE1 × avelumab × Thoracic × Clear all

NCT03158883 2021-10-20

UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients

Phase EARLY_PHASE1 Completed

Carcinoma, Non-Small-Cell Lung